The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBowleven Regulatory News (BLVN)

Share Price Information for Bowleven (BLVN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.20
High: 0.20
Low: 0.175
Prev. Close: 0.20
BLVN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Etinde Exploitation Authorisation Awarded

4 Aug 2014 07:00

RNS Number : 0899O
BowLeven Plc
04 August 2014
 



 

 

 

4 August 2014

 

Bowleven plc ('Bowleven' or 'the Company')

 

Etinde Exploitation Authorisation Awarded

 

Bowleven, the Africa focused oil and gas exploration group traded on AIM, is pleased to announce that the formal decree awarding the Etinde Exploitation Authorisation (EA) has been signed by the President of Cameroon. This concludes the final stage of the EA award process. This EA gives Bowleven and its joint venture partners, which will include SNH, the Cameroon State oil company, development and exploitation rights over block MLHP-7 for an initial period of 20 years with the option to renew for up to a further 10 years.

 

The award of the EA is a significant milestone in plans to develop the Etinde Permit and in monetising our resources. Initial development plans are focused on the IM field on block MLHP-7 and initial dry gas sales are envisaged to be to a proposed fertiliser plant enabling liquids production. With significant upside potential on the Permit, additional gas offtake solutions are also being considered, in particular CLNG. The transaction with LUKOIL and NewAge, announced on 24 June 2014, enables accelerated appraisal drilling, aimed at confirming the additional resources available for the expanding range of gas sales opportunities.

 

The formal award of the EA satisfies one of the remaining conditions of the LUKOIL and NewAge farm-out transaction. Approval by the Cameroon government of the transfer of the equity interest and operatorship is the principal condition still to be satisfied.

 

Kevin Hart, Chief Executive of Bowleven plc, said:

"We are delighted that the Etinde Exploitation Authorisation has been officially awarded by Head of State, H.E. President Paul Biya. The award is a significant milestone and enables the progression of the exciting development plans on Etinde. This is an important project for Cameroon and we are pleased to be able to support the country in its aim to further develop its hydrocarbon resources".

 

 

ENQUIRIES

For further information please contact:

 

Bowleven plc

Kevin Hart, Chief Executive 00 44 131 524 5678

Kerry Crawford, Finance Director

 

Brunswick Group LLP

Patrick Handley 00 44 207 404 5959

Simon Maine

 

Bank of America Merrill Lynch (Nomad)

Derek Ross 00 44 207 628 1000

Tony White

 

Notes to Editors:

Bowleven is an African focused oil and gas exploration group, based in Edinburgh and traded on AIM. Bowleven's strategy is focused on creating and realising material value through exploration led organic growth. Bowleven holds equity interests in five blocks in Cameroon, with three blocks located offshore in shallow water and two onshore. All of these blocks are operated by Bowleven. Bowleven also holds an equity interest in an onshore block in Kenya, operated by Adamantine Energy, and has been awarded three blocks in Zambia, with applications on two blocks pending.

 

On 24 June 2014, Bowleven announced that the Group had entered into a conditional Sale and Purchase Agreement to sell an aggregate 50% interest (pre State back-in) in the Etinde Permit, Cameroon to LUKOIL and NewAge. Bowleven shareholders approved the transaction at a General Meeting on 21 July 2014. It is anticipated that on completion of the farm-out transaction operatorship of the offshore Etinde Permit in Cameroon will transfer to CAMOP.

 

 

Notes to Announcement: 

(1) The information in this release reflects the views and opinions of Bowleven as operator and has not been reviewed in advance by its joint venture partners.

 

Glossary of Terms:

The following are the main terms and abbreviations used in this announcement:

AIM

the market of that name operated by the London Stock Exchange

Bowleven

Bowleven plc (LSE:BLVN) and/or its subsidiaries as appropriate

CAMOP

Cameroon Offshore Petroleum S.A.R.L., the holder of a 25% non-operated participating interest (pre State back-in) in the Etinde Permit and an affiliate of NewAge

CLNG

Cameroon LNG, the GDF Suez S.A and SNH strategic partnership to advance the monetisation of the substantial undeveloped gas resource within Cameroon, via an in-country gas aggregations scheme to supply a LNG facility

EA

Exploitation Authorisation

IM

the Isongo Marine Field area, block MLHP-7, Etinde Permit

LNG

liquefied natural gas

LUKOIL

LUKOIL Overseas West Project Ltd, a subsidiary undertaking of OAO LUKOIL

NewAge

New Age (Africa Global Energy) Limited, the parent undertaking of CAMOP

SNH

Société Nationale des Hydrocarbures, the national oil and gas company of Cameroon

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSLFIFFLSEDA
Date   Source Headline
9th Apr 20243:43 pmRNSHolding(s) in Company
3rd Apr 202410:35 amRNSResults of Open Offer
2nd Apr 20241:43 pmRNSResult of General Meeting
27th Mar 20247:00 amRNSInterim Results
18th Mar 20247:54 amRNSHolding(s) in Company
15th Mar 20247:00 amRNSStandard form for notification of major holdings
14th Mar 20247:00 amRNSProposed Underwritten Open Offer to raise c$2m
12th Mar 20243:49 pmRNSHolding(s) in Company
25th Jan 202410:59 amRNSTermination of Transaction
6th Dec 20233:43 pmRNSRESULT OF ANNUAL GENERAL MEETING
15th Nov 20235:47 pmRNSPosting of Annual Report and Accounts 2023
10th Nov 20237:00 amRNSFull Year Results
9th Nov 20237:00 amRNSBlock Admission Six Monthly Return
26th Sep 20237:00 amRNSCorporate Update
21st Jul 20237:00 amRNSResponse to Share Price Movement
9th May 20237:00 amRNSBlock Admission Six Monthly Return
30th Mar 20237:00 amRNSInterim Results
25th Jan 202311:00 amRNSPrice Monitoring Extension
25th Jan 20239:05 amRNSSecond Price Monitoring Extn
25th Jan 20239:00 amRNSPrice Monitoring Extension
1st Dec 202211:48 amRNSRESULT OF ANNUAL GENERAL MEETING
9th Nov 20227:00 amRNSBlock Admission Six Monthly Return
7th Nov 20227:00 amRNSPosting of Annual Report and Accounts 2022
1st Nov 20224:41 pmRNSSecond Price Monitoring Extn
1st Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20227:30 amRNSFull Year Results
18th Aug 20224:41 pmRNSSecond Price Monitoring Extn
18th Aug 20224:35 pmRNSPrice Monitoring Extension
18th Aug 202211:05 amRNSSecond Price Monitoring Extn
18th Aug 202211:00 amRNSPrice Monitoring Extension
8th Jul 20227:00 amRNSChange of Partner and Operator at Etinde Licence
13th Jun 20222:05 pmRNSSecond Price Monitoring Extn
13th Jun 20222:00 pmRNSPrice Monitoring Extension
7th Jun 202211:00 amRNSPrice Monitoring Extension
7th Jun 20227:00 amRNSChange of Partner and Operator at Etinde Licence
23rd May 20222:05 pmRNSSecond Price Monitoring Extn
23rd May 20222:00 pmRNSPrice Monitoring Extension
9th May 20228:32 amRNSBlock Admission Six Monthly Review
30th Mar 20227:00 amRNSInterim Results
13th Dec 20212:06 pmRNSSecond Price Monitoring Extn
13th Dec 20212:01 pmRNSPrice Monitoring Extension
8th Dec 202111:53 amRNSRESULT OF ANNUAL GENERAL MEETING
15th Nov 20217:00 amRNSPosting of Annual Report and Accounts 2021
10th Nov 202111:05 amRNSSecond Price Monitoring Extn
10th Nov 202111:00 amRNSPrice Monitoring Extension
10th Nov 20217:00 amRNSFull Year Results
9th Nov 20218:55 amRNSBlock Admission Six Monthly Return
20th Aug 20214:41 pmRNSSecond Price Monitoring Extn
20th Aug 20214:36 pmRNSPrice Monitoring Extension
20th Aug 20212:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.